153 related articles for article (PubMed ID: 33509760)
1. [Ginsenoside 20(S)-Rg3 upregulates tumor suppressor VHL gene expression by suppressing DNMT3A-mediated promoter methylation in ovarian cancer cells].
Wang L; Han X; Zheng X; Zhou Y; Hou H; Chen W; Li X; Zhao L
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):100-106. PubMed ID: 33509760
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.
Zhou Y; Zheng X; Lu J; Chen W; Li X; Zhao L
Cell Physiol Biochem; 2018; 45(6):2548-2559. PubMed ID: 29558748
[TBL] [Abstract][Full Text] [Related]
3. Effects of ginsenoside Rg3 on epigenetic modification in ovarian cancer cells.
Zhao L; Shou H; Chen L; Gao W; Fang C; Zhang P
Oncol Rep; 2019 Jun; 41(6):3209-3218. PubMed ID: 31002353
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside 20(S)-Rg3 induced autophagy to inhibit migration and invasion of ovarian cancer.
Zheng X; Chen W; Hou H; Li J; Li H; Sun X; Zhao L; Li X
Biomed Pharmacother; 2017 Jan; 85():620-626. PubMed ID: 27899249
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside 20(S)-Rg3 upregulates HIF-1α-targeting miR-519a-5p to inhibit the Warburg effect in ovarian cancer cells.
Lu J; Chen H; He F; You Y; Feng Z; Chen W; Li X; Zhao L
Clin Exp Pharmacol Physiol; 2020 Aug; 47(8):1455-1463. PubMed ID: 32271958
[TBL] [Abstract][Full Text] [Related]
7. 20(S)-Rg3 upregulates FDFT1 via reducing miR-4425 to inhibit ovarian cancer progression.
Lu J; Zhou Y; Zheng X; Chen L; Tuo X; Chen H; Xue M; Chen Q; Chen W; Li X; Zhao L
Arch Biochem Biophys; 2020 Oct; 693():108569. PubMed ID: 32877662
[TBL] [Abstract][Full Text] [Related]
8. The Role of Abnormal Methylation of Wnt5a Gene Promoter Regions in Human Epithelial Ovarian Cancer: A Clinical and Experimental Study.
Jin P; Song Y; Yu G
Anal Cell Pathol (Amst); 2018; 2018():6567081. PubMed ID: 30079293
[TBL] [Abstract][Full Text] [Related]
9. [Antiangiogenesis of ginsenoside Rg3 in severe combined immunodeficient mice with human ovarian carcinoma].
Pan Z; Ye D; Xie X; Chen H; Lu W
Zhonghua Fu Chan Ke Za Zhi; 2002 Apr; 37(4):227-30. PubMed ID: 12133417
[TBL] [Abstract][Full Text] [Related]
10. The von Hippel Lindau tumour suppressor gene is a novel target of E2F4-mediated transcriptional repression in preeclampsia.
Alahari S; Garcia J; Post M; Caniggia I
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3298-3308. PubMed ID: 30053437
[TBL] [Abstract][Full Text] [Related]
11. The von Hippel-Lindau (VHL) tumor-suppressor gene is down-regulated by selenium deficiency in Caco-2 cells and rat colon mucosa.
Uthus E; Begaye A; Ross S; Zeng H
Biol Trace Elem Res; 2011 Aug; 142(2):223-31. PubMed ID: 20632125
[TBL] [Abstract][Full Text] [Related]
12. Effects of R type and S type ginsenoside Rg3 on DNA methylation in human hepatocarcinoma cells.
Teng S; Wang Y; Li P; Liu J; Wei A; Wang H; Meng X; Pan D; Zhang X
Mol Med Rep; 2017 Apr; 15(4):2029-2038. PubMed ID: 28260016
[TBL] [Abstract][Full Text] [Related]
13. 20(S)-Rg3 blocked epithelial-mesenchymal transition through DNMT3A/miR-145/FSCN1 in ovarian cancer.
Li J; Lu J; Ye Z; Han X; Zheng X; Hou H; Chen W; Li X; Zhao L
Oncotarget; 2017 Aug; 8(32):53375-53386. PubMed ID: 28881818
[TBL] [Abstract][Full Text] [Related]
14. [Methylation and demethylation of SOX2 gene promoter in BGC-823 gastric cancer cells].
Wei B; Liu G; Cai HL; Li GP; Huang HQ; Luo Q; Huang ZJ
Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(32):2548-53. PubMed ID: 27596549
[TBL] [Abstract][Full Text] [Related]
15. miR-603 targeted hexokinase-2 to inhibit the malignancy of ovarian cancer cells.
Lu J; Wang L; Chen W; Wang Y; Zhen S; Chen H; Cheng J; Zhou Y; Li X; Zhao L
Arch Biochem Biophys; 2019 Jan; 661():1-9. PubMed ID: 30365936
[TBL] [Abstract][Full Text] [Related]
16. VHL gene methylation contributes to excessive erythrocytosis in chronic mountain sickness rat model by upregulating the HIF-2α/EPO pathway.
Yang M; Zhu M; Song K; Wuren T; Yan J; Ge RL; Ji L; Cui S
Life Sci; 2021 Feb; 266():118873. PubMed ID: 33309718
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis.
Xu TM; Cui MH; Xin Y; Gu LP; Jiang X; Su MM; Wang DD; Wang WJ
Chin Med J (Engl); 2008 Aug; 121(15):1394-7. PubMed ID: 18959116
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside 20(S)-Rg3 suppresses ovarian cancer migration via hypoxia-inducible factor 1 alpha and nuclear factor-kappa B signals.
Liu T; Zhao L; Hou H; Ding L; Chen W; Li X
Tumour Biol; 2017 May; 39(5):1010428317692225. PubMed ID: 28459376
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
20. The in vitro and in vivo effects of re-expressing methylated von Hippel-Lindau tumor suppressor gene in clear cell renal carcinoma with 5-aza-2'-deoxycytidine.
Alleman WG; Tabios RL; Chandramouli GV; Aprelikova ON; Torres-Cabala C; Mendoza A; Rogers C; Sopko NA; Linehan WM; Vasselli JR
Clin Cancer Res; 2004 Oct; 10(20):7011-21. PubMed ID: 15501981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
